You are here : Home > Research Centers and Units > IDMIT > OncoDesign



OncoDesign is a biopharmaceutical company engaged in the discovery of effective therapies for the benefit of patients with pathology without therapeutic solution. 

Published on 4 September 2018

Pioneers of translational medicine, from the creation of new experimental models to the development of new approaches to assess the efficacy of treatments, such as pharmaco-imaging. OncoDesign is particularly interested in kinases, a family of key enzymes in the maintenance of cellular homeostasis: their deregulation is at the origin of many pathologies. OncoDesign develops both potent and specific inhibitors of the targeted kinases, which are then tested for their therapeutic potential.

Human kinome. © OncoDesign

Top page